TY - JOUR
T1 - Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b
AU - Shibata, Kensuke
AU - Motozono, Chihiro
AU - Nagae, Masamichi
AU - Shimizu, Takashi
AU - Ishikawa, Eri
AU - Motooka, Daisuke
AU - Okuzaki, Daisuke
AU - Izumi, Yoshihiro
AU - Takahashi, Masatomo
AU - Fujimori, Nao
AU - Wing, James B.
AU - Hayano, Takahide
AU - Asai, Yoshiyuki
AU - Bamba, Takeshi
AU - Ogawa, Yoshihiro
AU - Furutani-Seiki, Makoto
AU - Shirai, Mutsunori
AU - Yamasaki, Sho
N1 - Funding Information:
We thank S. Iwai, M. Kurata, S. Mondoon, M. Kawano, M. Shiokawa, K. Toyonaga, A. Kubota, X. Lu, Y. Harima, A. Tanaka, E. Ito, T. Oono, K. Kawabe, D. N. Azizah and T. Ito for technical support; S. Inuki, KH. Sonoda and Y. Yoshikai for discussions; M. Tanaka and K. Kaseda for embryonic engineering; the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University and Science Research Center of Yamaguchi University for technical support. We also thank the beamline staff at the Photon Factory for crystallographic data collection. This research was supported by AMED (JP20gm0910010, JP20ak0101070, and JP20fk0108075), JSPS KAKENHI (JP20H00505 and JP16K08740), the Kurozumi Medical Foundation (K.S.), and the Takeda Science foundation (M.F.S.). The MR1 tetramer technology was developed jointly by Dr. James McCluskey, Dr. Jamie Rossjohn, and Dr. David Fairlie, and the material was produced by the NIH Tetramer Core Facility as permitted to be distributed by the University of Melbourne.
Funding Information:
We thank S. Iwai, M. Kurata, S. Mondoon, M. Kawano, M. Shiokawa, K. Toyonaga, A. Kubota, X. Lu, Y. Harima, A. Tanaka, E. Ito, T. Oono, K. Kawabe, D. N. Azizah and T. Ito for technical support; S. Inuki, KH. Sonoda and Y. Yoshikai for discussions; M. Tanaka and K. Kaseda for embryonic engineering; the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University and Science Research Center of Yamaguchi University for technical support. We also thank the beamline staff at the Photon Factory for crystallographic data collection. This research was supported by AMED (JP20gm0910010, JP20ak0101070, and JP20fk0108075), JSPS KAKENHI (JP20H00505 and JP16K08740), the Kurozumi Medical Foundation (K.S.), and the Takeda Science foundation (M.F.S.). The MR1 tetramer technology was developed jointly by Dr. James McCluskey, Dr. Jamie Rossjohn, and Dr. David Fairlie, and the material was produced by the NIH Tetramer Core Facility as permitted to be distributed by the University of Melbourne.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - MHC class I-related protein 1 (MR1) is a metabolite-presenting molecule that restricts MR1-reactive T cells including mucosal-associated invariant T (MAIT) cells. In contrast to MAIT cells, the function of other MR1-restricted T cell subsets is largely unknown. Here, we report that mice in which a T cell-specific transcription factor, B-cell lymphoma/leukemia 11B (Bcl11b), was ablated in immature thymocytes (Bcl11b∆iThy mice) develop chronic inflammation. Bcl11b∆iThy mice lack conventional T cells and MAIT cells, whereas CD4+IL-18R+ αβ T cells expressing skewed Traj33 (Jα33)+ T cell receptors (TCR) accumulate in the periphery, which are necessary and sufficient for the pathogenesis. The disorders observed in Bcl11b∆iThy mice are ameliorated by MR1-deficiency, transfer of conventional T cells, or germ-free conditions. We further show the crystal structure of the TCR expressed by Traj33+ T cells expanded in Bcl11b∆iThy mice. Overall, we establish that MR1-reactive T cells have pathogenic potential.
AB - MHC class I-related protein 1 (MR1) is a metabolite-presenting molecule that restricts MR1-reactive T cells including mucosal-associated invariant T (MAIT) cells. In contrast to MAIT cells, the function of other MR1-restricted T cell subsets is largely unknown. Here, we report that mice in which a T cell-specific transcription factor, B-cell lymphoma/leukemia 11B (Bcl11b), was ablated in immature thymocytes (Bcl11b∆iThy mice) develop chronic inflammation. Bcl11b∆iThy mice lack conventional T cells and MAIT cells, whereas CD4+IL-18R+ αβ T cells expressing skewed Traj33 (Jα33)+ T cell receptors (TCR) accumulate in the periphery, which are necessary and sufficient for the pathogenesis. The disorders observed in Bcl11b∆iThy mice are ameliorated by MR1-deficiency, transfer of conventional T cells, or germ-free conditions. We further show the crystal structure of the TCR expressed by Traj33+ T cells expanded in Bcl11b∆iThy mice. Overall, we establish that MR1-reactive T cells have pathogenic potential.
UR - http://www.scopus.com/inward/record.url?scp=85141990181&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141990181&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-34802-8
DO - 10.1038/s41467-022-34802-8
M3 - Article
C2 - 36376329
AN - SCOPUS:85141990181
VL - 13
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
IS - 1
M1 - 6948
ER -